AGENTS FOR TREATING DISEASE

Provided are methods of screening to identify molecules capable of binding to CD4 and capable of activating CD4+CD25+ regulatory T cells. Further provided are antibodies and antibody fragments capable of activating CD4+CD25+ regulatory T cells and methods and uses involving the antibodies and fragme...

Full description

Saved in:
Bibliographic Details
Main Authors DAELKEN BENJAMIN, UHEREK CHRISTOPH, CZELOTH NIKLAS, WALLMEIER HOLGER, VOELP KIRSTEN, BRUECHER CHRISTOPH, ZUBER CHANTAL, SCHULZ GREGOR, OSTERROTH FRANK, ENGLING ANDRE
Format Patent
LanguageEnglish
Korean
Published 18.09.2012
Subjects
CHEMISTRY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:Provided are methods of screening to identify molecules capable of binding to CD4 and capable of activating CD4+CD25+ regulatory T cells. Further provided are antibodies and antibody fragments capable of activating CD4+CD25+ regulatory T cells and methods and uses involving the antibodies and fragments thereof.
Bibliography:Application Number: KR20127016947